Lilly's Jake Van Naarden is meeting myeloma experts at ASCO to figure out the best possible path for phase 3 trials of Kelonia's in vivo CAR-T prospect. (Darren Incorvaia) Kelonia Therapeutics has ...
A French multinational, Schneider Electric, decided to use artificial intelligence in manufacturing to make workers more productive, rather than to replace them. Here’s how that’s going. A French ...
WASHINGTON, May 28 (Reuters) - U.S. forces deployed to war zones have been targeted using commercially available location data, according to reports fielded by military officials, an illustration of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results